Log In
Print
BCIQ
Print
Print this Print this
 

triheptanoin (UX007)

  Manage Alerts
Collapse Summary General Information
Company Ultragenyx Pharmaceutical Inc.
DescriptionSynthetic compound that provides medium-length, odd-chain fatty acids that are metabolized to replace intermediate substrates in fatty acid oxidation and in the tricarboxylic acid (TCA) cycle
Molecular Target
Mechanism of ActionSubstrate replacement therapy
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today